Noventra Pharma | Tirzepatide 30mg | Compound Peptide Vial
High-Strength Dual Incretin Metabolic Research Compound
Tirzepatide is an investigational peptide studied for its dual receptor activity across GLP-1 and GIP pathways.
It is widely referenced in scientific research exploring incretin signalling, metabolic regulation mechanisms, and peptide-receptor interaction pathways within controlled laboratory environments.
Developed as a 30mg vial research compound, this formulation is designed for laboratory preparation and controlled investigation where metabolic signalling and receptor activity profiling are of interest.
🧪 Key Benefits – Noventra Pharma Tirzepatide 30mg Compound Peptide Vial
• Dual GLP-1 and GIP receptor research compound
• Investigated in incretin pathway and metabolic signalling research models
• Of interest in peptide receptor interaction studies
• 30mg vial format designed for laboratory preparation use
• Studied in metabolic and endocrine research contexts
• High-purity investigational formulation from Noventra Pharma
• Manufactured for stability, consistency, and research reliability
• Strictly intended for laboratory research use only
⚖️ DISCLAIMER
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPHRA) for human or animal use.
This product is supplied strictly for laboratory research purposes only and is not intended for human consumption.
Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease.
By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
